Halozyme Therapeutics (NASDAQ:HALO) shares declined pre-market Wednesday, after the biopharmaceutical company said it was informed by the Food and Drug Administration that a clinical hold has been placed on patient enrolment and dosing of its PEGPH20 in an ongoing Phase 2 trial evaluating PEGPH20 in patients with pancreatic cancer. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock opened today at $7.97 and is currently trading at $8.15. The stock showed a negative weekly performance of -32.66%.
Randgold Resources (NASDAQ:GOLD)‘s stock had its “buy” rating restated by Deutsche Bank in a research note issued on Tuesday, American Banking News reports. Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) stock opened at $78.53, in current trading session and currently is at $77.47, by losing -3.14%. The 52 week range of $59.19 – $85.48. Company’s market capitalization is 7.15 billion.
NASDAQ OMX Group Inc. (NASDAQ:NDAQ) has now become the first exchange operator to receive approval for its Stockholm-based clearing house to operate under new European Union trading rules that regulate derivatives trading. NASDAQ OMX Group, Inc. (NASDAQ:NDAQ) stock is currently trading at $34.25. The EPS of the stock is 2.24. Company’s market capitalization is 5.83 billion.
Citrix Systems, Inc. (NASDAQ:CTXS) is working with Google to deliver business-critical Windows apps to Google Chromebooks. Chromebooks are experiencing rapidly growing adoption across organizations of all types, including many of the largest enterprises, as they look to transition to new and innovative computing platforms. Citrix Systems, Inc. (NASDAQ:CTXS) stock opened the session at $55.29, and now is at $56.14. The 52 week range of the Citrix Systems, Inc. (NASDAQ:CTXS) stock remained $51.18 – $77.16 and the day range was $55.29 – $56.33.